News

Filter

Current filters:

None

7867 to 7876 of 98149 results

New Zealand's PHARMAC lifts restrictions on some cancer drugs

09-12-2012

New Zealand's Pharmaceutical Management Agency PHARMAC has removed the Special Authority funding requirements…

Asia-PacificOncologyPharmaceuticalRegulation

Alfa Wassermann and Norgine get EU approval for Xifaxan

09-12-2012

Italy-based Alfa Wassermann and Netherlands-headquartered Norgine say they have received European Marketing…

Alfa WassermannAntibiotics and Infectious diseasesEuropeNorginePharmaceuticalRegulationXifaxan

Dr Reddy's launches Debiopharm's cancer drug Pamorelin LA in India

09-12-2012

Independent Swiss biopharma firm Debiopharm Group announced on Friday that, on December 3, Dr. Reddy's…

Asia-PacificDebiopharmDr Reddy's LaboratoriesLicensingMarkets & MarketingOncologyPamorelinPharmaceutical

EU Court of Justice dismisses AstraZeneca appeal on patent settlement

07-12-2012

The European Union's highest court, the Court of Justice, yesterday dismissed the appeal of Anglo-Swedish…

AstraZenecaEuropeGastro-intestinalsLegalLosecPatentsPharmaceutical

UK pharma group slams NICE for failing to recognize nature of discovery and development

07-12-2012

The Association of the British Pharmaceutical Industry (ABPI) yesterday expressed major concern on behalf…

EsbrietEuropeInterMunePharmaceuticalPricingRegulation

Protalix and Pfizer expand Elelyso agreement

07-12-2012

Israeli drug developer Protalix BioTherapeutics (NYSE-AMEX: OLX) said yesterday that it has entered into…

ElelysoLicensingPfizerPharmaceuticalProtalix BioTherapeuticsRare diseasesResearch

IMI debuts seven drug development project, valued at 237 million euros

07-12-2012

The Innovative Medicines Initiative (IMI), a joint undertaking between the European Union and the European…

BiotechnologyEuropeFinancialPharmaceuticalResearchRoche

7867 to 7876 of 98149 results

Back to top